# Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase

> **NCT00369187** · PHASE4 · COMPLETED · sponsor: **Halozyme Therapeutics** · enrollment: 15 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** large protein molecule

## Key facts

- **NCT ID:** NCT00369187
- **Lead sponsor:** Halozyme Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2006-10
- **Target enrollment:** 15 (—)
- **Last updated:** 2008-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00369187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00369187, "Study of a Large Protein Molecule Administered With Escalating Doses of Recombinant Human Hyaluronidase". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00369187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*